Method and kit for testing potency of immunoglobulin compositions
AssigneeBiotest AG
InventorsKatharina Heim, Marcus Gutscher
Life of this patent
Estimating the term…
Loading patent…
AssigneeBiotest AG
InventorsKatharina Heim, Marcus Gutscher
Estimating the term…
The present invention relates to the field of immunotherapeutics. It provides a method for characterisation and quality control, in particular for determining the potency of an immunoglobulin composition comprising immunoglobulins derived from a plurality of human donors, the method comprising contacting the immunoglobulin composition with pneumolysin, adding erythrocytes to the immunoglobulin composition and determining lysis of the erythrocytes. The invention also provides a corresponding use of pneumolysin, as well as a kit and composition useful in said method. The method can be used for quality control of immunoglobulin concentrate, e.g., of an IgM-containing immunoglobulin composition comprising IgM, IgA and IgG antibodies, and in a method of preparing an immunoglobulin composition. The immunoglobulin compositions obtainable from said method may be used, e.g., in the treatment of pneumonia, e.g., severe community-acquired pneumonia, which may be caused, e.g., by Streptococcus pneumoniae.
A method for characterisation of potency and/or quality control of an immunoglobulin composition comprising at least 30 g/L immunoglobulin derived from a plurality of human donors, the method comprising
A kit comprising
A composition comprising a standard human immunoglobulin composition comprising about 23% IgM, about 56% IgG and about 21% IgA (w/total antibody w), and pneumolysin, wherein the composition further comprises erythrocytes.
Dependencies are inferred from the claim text.